The role of the arginine vasopressin Avp1b receptor in the acute neuroendocrine action of antidepressants

被引:31
作者
Stewart, Lesley Q. [1 ]
Roper, James A. [1 ]
Young, W. Scott, III [2 ]
O'Carroll, Anne-Marie [1 ]
Lolait, Stephen J. [1 ]
机构
[1] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol BS1 3NY, Avon, England
[2] NIMH, Sect Neural Gene Express, NIH, DHHS, Bethesda, MD 20892 USA
基金
英国惠康基金;
关键词
vasopressin; Avp1b receptor; ACTH; corticosterone; antidepressants;
D O I
10.1016/j.psyneuen.2007.12.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In times of stress the hypothalamic-pituitary-adrenal (HPA) axis is activated and releases two neurohormones, corticotropin-releasing hormone (Crh) and arginine vasopressin (Avp), to synergistically stimulate the secretion of adrenocorticotropin hormone (ACTH) from the anterior pituitary, culminating in a rise in circulating glucocorticoids. Avp mediates its actions at the Avp V1b receptor (Avpr1b) present on pituitary corticotropes. Dysregulation of the stress response is associated with the pathophysiology of depression and a major treatment involves increasing the availability of monamines at the synaptic cleft. Acute administration of selective serotonin reuptake inhibitors (SSRI) and tricyclic antidepressants (TCA) has previously been shown to activate the HPA axis. The present study was undertaken to evaluate the involvement of the Avpr1b in the HPA axis response to acute SC administration of an SSRI (fluoxetine 10mg/kg) and a TCA (desipramine 10mg/kg). We measured plasma ACTH and corticosterone (CORT) levels and neuropeptide mRNA expression in the hypothalamic paraventricular nucleus (PVN) of Avpr1b knockout (KO) mice and wildtype controls. Fluoxetine and desipramine administration significantly attenuated plasma ACTH and CORT levels in mate and female Avpr1b KO mice when compared to their wild-type counterparts. Avp, oxytocin (Oxt) and Crh mRNA expression in the PVN did not change in fluoxetine-treated mate Avpr1b KO or wild-type mice. In contrast, fluoxetine treatment increased PVN Avp mRNA levels in female Avpr1b wild type but not KO animals. PVN Oxt mRNA levels increased in fluoxetine-treated female mice of both genotypes. The data suggests that the Avpr1b is required to drive the HPA axis response to acute antidepressant treatment and provides further evidence of a sexual dichotomy in the regulation of PVN Avp/Oxt gene expression following antidepressant administration. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:405 / 415
页数:11
相关论文
共 81 条
  • [1] Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation
    Aguilera, G
    Rabadan-Diehl, C
    [J]. REGULATORY PEPTIDES, 2000, 96 (1-2) : 23 - 29
  • [2] Negative regulation of corticotropin releasing factor expression and limitation of stress response
    Aguilera, Greti
    Kiss, Alexander
    Liu, Ying
    Kamitakahara, Anna
    [J]. STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, 2007, 10 (02): : 153 - 161
  • [3] [Anonymous], 2000, CONSULT PHARMACIST
  • [4] [Anonymous], NEUROENDOCRINOLOGY
  • [5] [Anonymous], 2002, PHARM EXP THER, DOI DOI 10.1124/JPET.102.036749
  • [6] VASOPRESSINERGIC CONTROL OF PITUITARY ADRENOCORTICOTROPIN SECRETION COMES OF AGE
    ANTONI, FA
    [J]. FRONTIERS IN NEUROENDOCRINOLOGY, 1993, 14 (02) : 76 - 122
  • [7] EVIDENCE THAT THE EFFECTS OF ARGININE-8-VASOPRESSIN (AVP) ON PITUITARY CORTICOTROPIN (ACTH) RELEASE ARE MEDIATED BY A NOVEL TYPE OF RECEPTOR
    ANTONI, FA
    HOLMES, MC
    MAKARA, GB
    KARTESZI, M
    LASZLO, FA
    [J]. PEPTIDES, 1984, 5 (03) : 519 - 522
  • [8] Armario Antonio, 2006, CNS & Neurological Disorders-Drug Targets, V5, P485, DOI 10.2174/187152706778559336
  • [9] Endotoxin decreases corticotropin-releasing factor receptor 1 messenger ribonucleic acid levels in the rat pituitary
    Aubry, JM
    Turnbull, AV
    Pozzoli, G
    Rivier, C
    Vale, W
    [J]. ENDOCRINOLOGY, 1997, 138 (04) : 1621 - 1626
  • [10] Barberis C, 1996, CRIT REV NEUROBIOL, V10, P119